Insider trading

Period: 120 months Stock: IRON + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

164 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

164 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

164 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

164 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
164 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
164 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

164 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
17 Jun 2024
Ashiya Mona Director · indirect
Bought 3×
$3.00M 83,334 at 36.00
9.7%
Largest buy in 3 yrs
17 Jun 2024
ORBIMED ADVISORS LLC Director · indirect
Bought 3×
$3.00M 83,334 at 36.00
9.7%
Largest buy in 3 yrs
3 Jun 2024
Sold on a plan 3×
$70.61K 1,957 at 36.08
100%
Sold half or more
1 May 2024
Sold on a plan 2×
$5.75K 201 at 28.63
100%
Sold half or more
11 Apr 2024
Sold on a plan 2×
$81.41K 2,560 at 31.80
100%
Sold half or more
5 Mar 2024
Bitterman Kevin Director · indirect
Sold at will
$1.92M 26,157 at 73.50
3.7%
Not planned
23 Jan 2024
Bitterman Kevin Director · indirect
Sold at will 2×
$6.93M 102,500 at 67.65
34.1%
Not planned
23 Jan 2024
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold at will 2×
$6.93M 102,500 at 67.65
34.1%
Not planned
23 Jan 2024
Sold at will
$3.21M 47,500 at 67.65
3.3%
Not planned
10 Jan 2024
Sold at will
$1.92M 30,000 at 64.00
2.0%
Not planned
10 Jan 2024
Bitterman Kevin Director · indirect
Sold at will
$1.28M 20,000 at 64.00
2.5%
Not planned
10 Jan 2024
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold at will
$1.28M 20,000 at 64.00
2.5%
Not planned
18 Dec 2023
Sold at will
$102.13K 1,724 at 59.24
100%
Sold half or more
18 Dec 2023
Ashiya Mona Director
Sold at will
$102.13K 1,724 at 59.24
100%
Sold half or more
14 Dec 2023
Ashiya Mona Director · indirect
Sold at will 5×
$24.60M 433,400 at 56.75
65.9%
Sold half or more
14 Dec 2023
ORBIMED ADVISORS LLC Director · indirect
Sold at will 5×
$24.60M 433,400 at 56.75
65.9%
Sold half or more
14 Dec 2023
Sold at will 2×
$1.80M 30,825 at 58.28
2.0%
Not planned
14 Dec 2023
Bitterman Kevin Director · indirect
Sold at will 2×
$1.20M 20,549 at 58.28
2.5%
Not planned
14 Dec 2023
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold at will 2×
$1.20M 20,549 at 58.28
2.5%
Not planned
13 Dec 2023
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$6.25M 106,700 at 58.56
27.5%
Not planned
13 Dec 2023
Ashiya Mona Director · indirect
Sold at will 3×
$6.25M 106,700 at 58.56
27.5%
Not planned
13 Dec 2023
Sold at will 2×
$319.36K 5,323 at 60.00
0.4%
Not planned
13 Dec 2023
Bitterman Kevin Director · indirect
Sold at will 2×
$212.86K 3,548 at 60.00
0.4%
Not planned
13 Dec 2023
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold at will 2×
$212.86K 3,548 at 60.00
0.4%
Not planned
12 Dec 2023
Sold at will 7×
$4.90M 77,951 at 62.80
4.9%
Not planned
12 Dec 2023
Bitterman Kevin Director · indirect
Sold at will 7×
$3.26M 51,967 at 62.80
5.9%
Not planned
12 Dec 2023
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold at will 7×
$3.26M 51,967 at 62.80
5.9%
Not planned
12 Dec 2023
Sold at will 4×
$2.12M 33,511 at 63.21
100%
Sold half or more
12 Dec 2023
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$1.64M 27,300 at 60.16
8.5%
Not planned
12 Dec 2023
Ashiya Mona Director · indirect
Sold at will 3×
$1.64M 27,300 at 60.16
8.5%
Not planned
12 Dec 2023
Bryce Joanne Chief Financial Officer
Sold on a plan
$163.06K 2,500 at 65.22
50.0%
Sold half or more
5 Dec 2023
Bryce Joanne Chief Financial Officer
Sold on a plan 3×
$142.30K 2,541 at 56.00
50.4%
Sold half or more
22 Nov 2023
Khara Rahul General Counsel
Sold on a plan 2×
$517.33K 10,000 at 51.73
100%
Sold half or more
14 Nov 2023
Khara Rahul General Counsel
Sold on a plan 2×
$248.01K 4,900 at 50.61
100%
Sold half or more
3 Nov 2023
Khara Rahul General Counsel
Sold on a plan
$5.00K 100 at 50.00
100%
Sold half or more
16 Sep 2023
Sold at will
$112.56K 2,115 at 53.22
0.1%
Not planned
15 Sep 2023
Sold at will
$13.87M 260,894 at 53.16
14.1%
Not planned
14 Sep 2023
Sold at will
$5.01M 94,440 at 53.05
4.8%
Not planned
1 Sep 2023
Bryce Joanne Chief Financial Officer
Sold on a plan
$52.99K 1,000 at 52.99
44.2%
Planned (10b5-1)
15 Aug 2023
Sold at will
$5.82M 111,069 at 52.40
5.4%
Not planned
15 Aug 2023
Bitterman Kevin Director · indirect
Sold at will
$3.82M 72,931 at 52.40
7.6%
Not planned
15 Aug 2023
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold at will
$3.82M 72,931 at 52.40
7.6%
Not planned
15 Aug 2023
Savage William Jacob Chief Medical Officer
Sold on a plan 3×
$406.24K 7,672 at 52.95
100%
Sold half or more
14 Aug 2023
Sold at will 3×
$9.20M 175,000 at 52.59
7.8%
Not planned
9 Aug 2023
Savage William Jacob Chief Medical Officer
Sold on a plan 3×
$412.06K 8,269 at 49.83
51.9%
Sold half or more
1 Aug 2023
Bryce Joanne Chief Financial Officer
Sold on a plan 2×
$225.63K 4,521 at 49.91
78.2%
Sold half or more
30 Jun 2023
MacDonald Brian Richard Chief Innovation Officer
Sold on a plan 2×
$194.78K 4,324 at 45.05
25.1%
Planned (10b5-1)
30 Jun 2023
MacDonald Brian Richard Chief Innovation Officer
Bought on a plan
$28.06K 600 at 46.76
5.1%
Bought on a plan
29 Jun 2023
MacDonald Brian Richard Chief Innovation Officer
Sold on a plan 4×
$233.51K 5,100 at 45.79
22.9%
Planned (10b5-1)
28 Jun 2023
Novo Holdings A/S 10% owner
Sold at will
$57.63M 1,250,000 at 46.10
53.4%
Sold half or more
Showing 101–150 of 164. ← Newer Page 3 of 4 Older →